|
1
|
Chen AY, Jemal A and Ward EM: Increasing
incidence of differentiated thyroid cancer in the United States,
1988–2005. Cancer. 115:3801–3807. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Davies L and Welch HG: Increasing
incidence of thyroid cancer in the United States, 1973–2002. JAMA.
295:2164–2167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Voutilainen PE, Multanen MM, Leppäniemi
AK, Haglund CH, Haapiainen RK and Franssila KO: Prognosis after
lymph node recurrence in papillary thyroid carcinoma depends on
age. Thyroid. 11:953–957. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chou CK, Chen RF, Chou FF, Chang HW, Chen
YJ, Lee YF, Yang KD, Cheng JT, Huang CC and Liu RT: miR-146b is
highly expressed in adult papillary thyroid carcinomas with high
risk features including extrathyroidal invasion and the BRAF(V600E)
mutation. Thyroid. 20:489–494. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brown RL, de Souza JA and Cohen EE:
Thyroid cancer: Burden of illness and management of disease. J
Cancer. 2:193–199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chou CK, Yang KD, Chou FF, Huang CC, Lan
YW, Lee YF, Kang HY and Liu RT: Prognostic implications of miR-146b
expression and its functional role in papillary thyroid carcinoma.
J Clin Endocrinol Metab. 98:E196–E205. 2013. View Article : Google Scholar
|
|
7
|
Jazdzewski K, Liyanarachchi S, Swierniak
M, Pachucki J, Ringel MD, Jarzab B and de la Chapelle A:
Polymorphic mature microRNAs from passenger strand of pre-miR-146a
contribute to thyroid cancer. Proc Natl Acad Sci USA.
106:1502–1505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li M, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar
|
|
9
|
Vriens MR, Weng JL, Suh I, Huynh N,
Guerrero MA, Shen WT, Duh QY, Clark OH and Kebebew E: MicroRNA
expression profiling is a potential diagnostic tool for thyroid
cancer. Cancer. 118:3426–3432. 2012. View Article : Google Scholar
|
|
10
|
Zhong L, Sun S, Shi J, Cao F, Han X and
Chen Z: MicroRNA-125a 5p plays a role as a tumor suppressor in lung
carcinoma cells by directly targeting STAT3. Tumor Biol.
39:10104283176975792017. View Article : Google Scholar
|
|
11
|
Dong W, Li B, Wang J, Song Y, Zhang Z and
Fu C: MicroRNA-337 inhibits cell proliferation and invasion of
cervical cancer through directly targeting specificity protein 1.
Tumor Biol. 39:10104283177113232017. View Article : Google Scholar
|
|
12
|
Wang P, Chen S, Fang H, Wu X, Chen D, Peng
L, Gao Z and Xie C: miR-214/199a/199a* cluster levels
predict poor survival in hepatocellular carcinoma through
interference with cell-cycle regulators. Oncotarget. 7:929–945.
2016.
|
|
13
|
Zhang J, Su B, Gong C, Xi Q and Chao T:
miR-214 promotes apoptosis and sensitizes breast cancer cells to
doxorubicin by targeting the RFWD2-p53 cascade. Biochem Bioph Res
Co. 478:337–342. 2016. View Article : Google Scholar
|
|
14
|
Peng R, Men J, Ma R, Wang Q, Wang Y, Sun Y
and Ren J: miR-214 down-regulates ARL2 and suppresses growth and
invasion of cervical cancer cells. Biochem Bioph Res Co.
484:623–630. 2017. View Article : Google Scholar
|
|
15
|
Penna E, Orso F and Taverna D: miR-214 as
a key hub that controls cancer networks: Small player, multiple
functions. J Invest Dermatol. 135:960–969. 2015. View Article : Google Scholar
|
|
16
|
Hori T, Kato S, Saeki M, DeMartino GN,
Slaughter CA, Takeuchi J, Toh-e A and Tanaka K: cDNA cloning and
functional analysis of p28 (Nas6p) and p40.5 (Nas7p), two novel
regulatory subunits of the 26S proteasome. Gene. 216:113–122. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Higashitsuji H, Itoh K, Nagao T, Dawson S,
Nonoguchi K, Kido T, Mayer RJ, Arii S and Fujita J: Reduced
stability of retinoblastoma protein by gankyrin, an oncogenic
ankyrin-repeat protein overexpressed in hepatomas. Nat Med.
6:96–99. 2000. View
Article : Google Scholar
|
|
18
|
Zhen C, Chen L, Zhao Q, Liang B, Gu YX,
Bai ZF, Wang K, Xu X, Han QY, Fang DF, et al: Gankyrin promotes
breast cancer cell metastasis by regulating Rac1 activity.
Oncogene. 32:3452–3460. 2000. View Article : Google Scholar
|
|
19
|
Meng Y, He L, Guo X, Tang S, Zhao X, Du R,
Jin J, Bi Q, Li H, Nie Y, et al: Gankyrin promotes the
proliferation of human pancreatic cancer. Cancer Lett. 297:9–17.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Uddin MH, Choi MH, Kim WH, Jang JJ and
Hong ST: Involvement of PSMD10, CDK4, and tumor suppressors in
development of intrahepatic cholangiocarcinoma of syrian golden
hamsters induced by clonorchis sinensis and N-Nitrosodimethylamine.
PLoS Negl Trop Dis. 9:e00040082015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edge SB, Byrd DR, Compton CC, Fritz AG and
Greene FL: AJCC cancer staging manual. 7th edition. Springer; New
York, NY: 2010
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−delta delta C(T)) methods. Methods. 25:420–408. 2001.
View Article : Google Scholar
|
|
23
|
Agarwal V, Bell GW, Nam J and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar :
|
|
24
|
Xia H, Ooi LL and Hui KM: MiR-214 targets
β-catenin pathway to suppress invasion, stem-like traits and
recurrence of human hepatocellular harcinoma. PLoS One.
7:e442062012. View Article : Google Scholar
|
|
25
|
Mitra AK, Zillhardt M, Hua Y, Tiwari P,
Murmann AE, Peter ME and Lengyel E: MicroRNAs reprogram normal
fibroblasts into cancer-associated fibroblasts in ovarian cancer.
Cancer Discov. 2:1100–1108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang F, Liu M, Li X and Tang H: MiR-214
reduces cell survival and enhances cisplatin-induced cytotoxicity
via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett.
587:488–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Srivastava A, Goldberger H, Dimtchev A,
Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen
LN, et al: MicroRNA profiling in prostate cancer-the diagnostic
potential of urinary miR-205 and miR-214. PLoS One. 8:e769942013.
View Article : Google Scholar
|
|
28
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Derfoul A, Juan AH, Difilippantonio MJ,
Palanisamy N, Ried T and Sartorelli V: Decreased microRNA-214
levels in breast cancer cells coincides with increased cell
proliferation, invasion and accumulation of the Polycomb Ezh2
methyltransferase. Carcinogenesis. 32:1607–1614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Duan Q, Wang X, Gong W, Ni L, Chen C, He
X, Chen F, Yang L, Wang P and Wang DW: ER stress negatively
modulates the expression of the miR-199a/214 cluster to regulates
tumor survival and progression in human hepatocellular cancer. PLoS
One. 7:e315182012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Misiewicz-Krzeminska I, Sarasquete ME,
Quwaider D, Krzeminski P, Ticona FV, Paino T, Delgado M, Aires A,
Ocio EM, Garcia-Sanz R, et al: Restoration of microRNA-214
expression reduces growth of myeloma cells through positive
regulation of P53 and inhibition of DNA replication. Haematologica.
98:640–648. 2013. View Article : Google Scholar :
|
|
32
|
Huang SD, Yuan Y, Zhuang CW, Li BL, Gong
DJ, Wang SG, Zeng ZY and Cheng HZ: MicroRNA-98 and microRNA-214
post-transcriptionally regulate enhancer of zeste homolog 2 and
inhibit migration and invasion in human esophageal squamous cell
carcinoma. Mol Cancer. 11:512012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Penna E, Orso F, Cimino D, Tenaglia E,
Lembo A, Quaglino E, Poliseno L, Haimovic A, Osella-Abate S, De
Pittà C, et al: microRNA-214 contributes to melanoma tumour
progression through suppression of TFAP2C. EMBO J. 30:1990–2007.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang
DS, Luo HY, Wang F, Qiu MZ, Wang DS, Ren C, et al: Identification
of microRNA-214 as a negative regulator of colorectal cancer liver
metastasis via regulation of fibroglast growth factor 1 expression.
Hepatology. 60:598–609. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He F, Chen H, Yang P, Wu Q, Zhang T, Wang
C, Wei J, Chen Z, Hu H, Li W and Cao J: Gankyrin sustains
PI3K/GSK-3β/β-catenin signal activation and promotes colorectal
cancer aggressiveness and progression. Oncotarget. 7:81156–81171.
2016. View Article : Google Scholar : PubMed/NCBI
|
